Michael Hay

Michael leads Norstella’s Strategic Intelligence business unit with a focus on portfolio prioritization and evaluating the commercial aspects of a drug, disease and the market sector to assess risk, benchmark and predict future impact. His 21 years of experience have helped to shape the key products: Citeline, Datamonitor Healthcare, and Biomedtracker.